Form D CRESCENT CREDIT RISK
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 8-K PRA GROUP INC For: Sep 29
PRA GROUP INC false 0001185348 0001185348 2026-09-29 2026-09-29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): September 29, 2026
(Exact name of registrant as specified in its charter)
Delaware 000-50058 75-3078675
(State or... (continue reading...)
Form 485APOS BLACKROCK EQUITY DIVIDEN
Table of Contents
As filed with the Securities and Exchange Commission on September 29, 2026
Securities Act File No. 33-14517
Investment Company Act File No. 811-5178
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-1A
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ☒ Pre-Effective Amendment No. ☐ Post-Effective Amendment No. 66 ☒ and/or
Form 8-K NewAmsterdam Pharma Co For: Sep 29
false000193625800-00000000001936258us-gaap:CommonStockMember2026-09-292026-09-2900019362582026-09-292026-09-290001936258us-gaap:WarrantMember2026-09-292026-09-29
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 29, 2026
NewAmsterdam Pharma Company... (continue reading...)
Form 8-K PNC FINANCIAL SERVICES For: Sep 29
0000713676false00007136762026-09-292026-09-29UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-K CURRENT REPORTPursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 September 29, 2026 Date of Report (Date of earliest event reported)THE PNC FINANCIAL SERVICES GROUP, INC. (Exact name of registrant as specified in its charter)Commission File Number 001-09718 Pennsylvania25-1435979(State or other jurisdiction of(I.R.S. Employer... (continue reading...)
More SEC Filings
View Older Stories-
Form 6-K Maris Tech Ltd. For: Sep 29
-
Form 6-K MINISO Group Holding For: Sep 29
-
Form 6-K EShallGo Inc. For: Sep 29
-
Form 6-K Turbo Energy, S.A. For: Jun 30
-
Form 8-K Flash Sports & Media For: Sep 28
-
Form SC 14D9/A ACV Auctions Inc. Filed by: ACV Auctions Inc.
-
Form 10-K BION ENVIRONMENTAL TECHN For: Jun 30
-
Form 8-A12B FORD MOTOR CREDIT CO
-
Form D/A DVLP Investors 1 Mar
-
Form 8-K ALASKA AIR GROUP, INC. For: Sep 29
-
Form 8-K FORD MOTOR CREDIT CO For: Sep 29
-
Form D/A VL Pre Seed SPV a Series
-
Form 6-K Ryde Group Ltd For: Sep 29
-
Form 1-SA Standard Dental Labs For: Jun 30
-
Form 4 H World Group Ltd For: Sep 26 Filed by: Jin Hui
-
Form 8-K Keros Therapeutics, Inc. For: Sep 29
-
Form 6-K SaverOne 2014 Ltd. For: Sep 29
-
Form 8-A12B DYNEX CAPITAL INC
-
Form SC TO-T/A ACV Auctions Inc. Filed by: COPART INC
-
Form S-3ASR MERCANTILE BANK CORP
-
Form 6-K MINISO Group Holding For: Sep 29
-
Form D/A MCorp a Series of CGF202
-
Form 8-K Imunon, Inc. For: Sep 28
-
Form 8-K TOP Financial Group Ltd For: Sep 25
-
Form 8-K Bloomin' Brands, Inc. For: Sep 25
-
Form 8-K FIRST UNITED CORP/MD/ For: Sep 24
-
Form 8-K Allarity Therapeutics, For: Sep 28
-
Form 8-K SurgePays, Inc. For: Sep 28
-
Form RW Syra Health Corp
-
Form 6-K POWERBANK Corp For: Sep 29
-
Form 8-K ATOSSA THERAPEUTICS, For: Sep 29
-
Form 6-K RoyaLand Co Ltd. For: Sep 29
-
Form 8-K TransDigm Group INC For: Sep 28
-
Form N-23C-2 OFS Credit Company, Inc. For: Sep 29
-
Form 497J Tidal Trust I
-
Form D/A Sensori April 2026 a
-
Form D/A Dart Financial Corp
-
Form D/A Auvi Labs Heinz Ventures
-
Form 485BXT GraniteShares ETF Trust
-
Form 40-17F2 BNY MELLON HIGH YIELD Filed by: BNY MELLON HIGH YIELD STRATEGIES FUND
-
Form 40-17F2 BNY Mellon Investment Filed by: BNY Mellon Investment Funds I
-
Form 40-17F2 BNY Mellon Investment Filed by: BNY Mellon Investment Funds II, Inc.
-
Form 40-17F2 BNY Mellon Investment Filed by: BNY Mellon Investment Funds III
-
Form 40-17F2 BNY Mellon Investment Filed by: BNY Mellon Investment Funds IV, Inc.
-
Form NT 10-K VISIUM TECHNOLOGIES, For: Jun 30
-
Form 8-K Unicycive Therapeutics, For: Sep 28
-
Form D/A Declan Odyssey X a Serie
-
Form 8-K SOUNDTHINKING, INC. For: Sep 28
-
Form 485BXT GraniteShares ETF Trust
-
Form 424B2 TORONTO DOMINION BANK
